Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes
Authors
Keywords
-
Journal
NEUROPSYCHOPHARMACOLOGY
Volume 43, Issue 4, Pages 891-899
Publisher
Springer Nature
Online
2017-11-20
DOI
10.1038/npp.2017.282
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
- (2017) Joseph P Schacht et al. NEUROPSYCHOPHARMACOLOGY
- Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone
- (2016) Corey R. Roos et al. ADDICTION BIOLOGY
- Existing and Future Drugs for the Treatment of the Dark Side of Addiction
- (2016) George F. Koob et al. Annual Review of Pharmacology and Toxicology
- Social Network Moderators of Naltrexone and Behavioral Treatment Effects on Heavy Drinking in the COMBINE Study
- (2015) Matthew J. Worley et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- How Imaging Glutamate,γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal
- (2015) Ansel T. Hillmer et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Heterogeneity of Alcohol Use Disorder: Understanding Mechanisms to Advance Personalized Treatment
- (2015) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Naltrexone vs Placebo for the Treatment of Alcohol Dependence
- (2015) David W. Oslin et al. JAMA Psychiatry
- Cognitive-Behavioral Treatment With Adult Alcohol and Illicit Drug Users: A Meta-Analysis of Randomized Controlled Trials
- (2015) Molly Magill et al. Journal of Studies on Alcohol and Drugs
- Predicting Naltrexone Response in Alcohol-Dependent Patients: The Contribution of Functional Magnetic Resonance Imaging
- (2014) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings
- (2014) Daniel E. Jonas et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A systems medicine research approach for studying alcohol addiction
- (2013) Rainer Spanagel et al. ADDICTION BIOLOGY
- Efficacy of As-Needed Nalmefene in Alcohol-Dependent Patients with at Least a High Drinking Risk Level: Results from a Subgroup Analysis of Two Randomized Controlled 6-Month Studies
- (2013) W. van den Brink et al. ALCOHOL AND ALCOHOLISM
- The Placebo Effect in Clinical Trials for Alcohol Dependence: An Exploratory Analysis of 51 Naltrexone and Acamprosate Studies
- (2013) Raye Z. Litten et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Glutamatergic targets for new alcohol medications
- (2013) Andrew Holmes et al. PSYCHOPHARMACOLOGY
- Variation inOPRM1moderates the effect of desire to drink on subsequent drinking and its attenuation by naltrexone treatment
- (2012) Henry R. Kranzler et al. ADDICTION BIOLOGY
- Results of a double-blind, placebo-controlled pharmacotherapy trial in alcoholism conducted in Germany and comparison with the US COMBINE study
- (2012) Karl Mann et al. ADDICTION BIOLOGY
- Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review
- (2012) Joseph P. Schacht et al. ADDICTION BIOLOGY
- Reward and relief craving tendencies in patients with alcohol use disorders: Results from the PREDICT study
- (2012) Angelika Glöckner-Rist et al. ADDICTIVE BEHAVIORS
- Cigarette Smoking Predicts Differential Benefit from Naltrexone for Alcohol Dependence
- (2012) Lisa M. Fucito et al. BIOLOGICAL PSYCHIATRY
- Personalized Treatment of Alcohol Dependence
- (2012) Henry R. Kranzler et al. Current Psychiatry Reports
- Translational Magnetic Resonance Spectroscopy Reveals Excessive Central Glutamate Levels During Alcohol Withdrawal in Humans and Rats
- (2011) Derik Hermann et al. BIOLOGICAL PSYCHIATRY
- The Alcohol Clinical Trials Initiative (ACTIVE): Purpose and Goals for Assessing Important and Salient Issues for Medications Development in Alcohol Use Disorders
- (2011) Raymond F Anton et al. NEUROPSYCHOPHARMACOLOGY
- Searching for Responders to Acamprosate and Naltrexone in Alcoholism Treatment: Rationale and Design of thePredict Study
- (2009) Karl Mann et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Genome-wide Association Study of Alcohol Dependence
- (2009) Jens Treutlein et al. ARCHIVES OF GENERAL PSYCHIATRY
- Neurocircuitry of Addiction
- (2009) George F Koob et al. NEUROPSYCHOPHARMACOLOGY
- Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the blues
- (2009) Markus Heilig et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Effect of Naltrexone and Ondansetron on Alcohol Cue–Induced Activation of the Ventral Striatum in Alcohol-Dependent People
- (2008) Hugh Myrick et al. ARCHIVES OF GENERAL PSYCHIATRY
- Drugs for relapse prevention of alcoholism: ten years of progress
- (2008) Rainer Spanagel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started